Identification and Validation of a Prognostic Immune-Related Gene Signature in Esophageal Squamous Cell Carcinoma
Esophageal carcinoma (EC) is a common malignant cancer worldwide. Esophageal squamous cell carcinoma (ESCC), the main type of EC, is difficult to treat because of the widespread morbidity, high fatality rates, and low quality of life caused by postoperative complications and no specific molecular ta...
Main Authors: | Kai Xiong, Ziyou Tao, Zeyang Zhang, Jianyao Wang, Peng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.850669/full |
Similar Items
-
Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma
by: Jie Zhu, et al.
Published: (2020-01-01) -
An Integrated Analysis of Prognostic Signature and Immune Microenvironment in Tongue Squamous Cell Carcinoma
by: Yi Jin, et al.
Published: (2022-07-01) -
Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma
by: Jinfeng Zhang, et al.
Published: (2022-05-01) -
Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas
by: Tong Lu, et al.
Published: (2019-03-01) -
Leveraging single-cell and multi-omics approaches to identify MTOR-centered deubiquitination signatures in esophageal cancer therapy
by: Kang Tian, et al.
Published: (2024-12-01)